Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients-Reference-Cited by-同舟云学术

Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients

Published:2020-03 Issue: Volume:340 Page:577142
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Cantarín-Extremera Verónica,Jiménez-Legido María,Duat-Rodríguez Anna,García-Fernández Marta,Ortiz-Cabrera Nelmar Valentina,Ruiz-Falcó-Rojas María Luz,González-Gutiérrez-Solana Luis

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference33 articles.

1. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms;Alyu;Acta Neuropsychiatr.,2017

2. Febrile infection-related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG, PCDH19 mutations or rare copy number variations;Appenzeller;Dev. Med. Child Neurol.,2012

3. Innate and adaptive immunity in human epilepsies;Bauer;Epilepsia,2017

4. Interleukin 6-mediated endothelial barrier disturbances can be attenuated by blockade of the IL6 receptor expressed in brain microvascular endothelial cells;Blecharz-Lang;Transl. Stroke Res.,2018

5. Effects of Tocilizumab therapy on serum Interleukin-33 and Interleukin-6 levels in patients with rheumatoid arthritis;Choi;Arch. Rheumatol.,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second‐line immunotherapy in new onset refractory status epilepticus;Epilepsia;2024-03-02

2. Severe, Refractory Seizures;Medical Clinics of North America;2024-01

3. Treatment of cryptogenic new-onset refractory status epilepticus (C-NORSE) with tocilizumab: A case report;Internal Medicine;2024

4. Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay;Frontiers in Pediatrics;2023-11-21

5. Treatment of new onset refractory status epilepticus/febrile infection‐related epilepsy syndrome with tocilizumab in a child and a young adult;Epilepsia;2023-04-05